Trademark: 79275472
Word
ACAZEN
Status
Registered
Status Code
700
Status Date
Tuesday, January 26, 2021
Serial Number
79275472
Registration Number
6253453
Registration Date
Tuesday, January 26, 2021
Mark Type
4000
Filing Date
Thursday, November 21, 2019
Published for Opposition
Tuesday, November 10, 2020

Trademark Owner History

Classifications
5 Nutritional supplements for medical use; medicines, particularly phytopharmaceutical products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); active plant agents and plant extracts for medical use, namely, plant extracts for pharmaceutical purposes; pharmaceutical, veterinary and sanitary products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); dietetic substances in the nature of food and beverages for medical use, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical use, namely, biological preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical products for medical use, namely, chemical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical products, namely, chemical-pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for dental use, namely, medicines for treating dentalirritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for human medicine, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); radiological contrast substances for medical use; steroids

Trademark Events
Jun 7, 2021
Final Decision Transaction Processed By Ib
May 15, 2021
Change Of Name/Address Rec'd From Ib
Apr 30, 2021
Generic Madrid Transaction Sent To Ib
Apr 29, 2021
Generic Madrid Transaction Created
Apr 26, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jan 26, 2021
Registered-Principal Register
Nov 10, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 10, 2020
Published For Opposition
Nov 8, 2020
Notification Processed By Ib
Oct 21, 2020
Notification Of Possible Opposition Sent To Ib
Oct 21, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 21, 2020
Notification Of Notice Of Publication E-Mailed
Oct 6, 2020
Approved For Pub - Principal Register
Oct 6, 2020
Examiner's Amendment Entered
Oct 6, 2020
Notification Of Examiners Amendment E-Mailed
Oct 6, 2020
Examiners Amendment E-Mailed
Oct 6, 2020
Examiners Amendment -Written
Sep 25, 2020
Teas/Email Correspondence Entered
Sep 24, 2020
Correspondence Received In Law Office
Sep 24, 2020
Teas Response To Office Action Received
Apr 10, 2020
Refusal Processed By Ib
Mar 24, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Mar 24, 2020
Refusal Processed By Mpu
Mar 4, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Mar 3, 2020
Non-Final Action Written
Feb 25, 2020
Assigned To Examiner
Jan 14, 2020
Application Filing Receipt Mailed
Jan 8, 2020
New Application Office Supplied Data Entered In Tram
Jan 2, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24